What Prasad’s exit means for the FDA moving forwardnews2026-03-09T17:51:46+00:00March 9th, 2026|Endpoints News|
Incyte receives CRL over issues at Novo’s Indiana factorynews2026-03-09T13:21:57+00:00March 9th, 2026|Endpoints News|
Vinay Prasad to exit FDA again, following latest round of controversynews2026-03-06T22:16:03+00:00March 6th, 2026|Endpoints News|
FDA official questions need for advisory committeesnews2026-03-06T01:46:00+00:00March 6th, 2026|Endpoints News|
FDA approves J&J’s multiple myeloma combo as second-line treatmentnews2026-03-05T19:59:40+00:00March 5th, 2026|Endpoints News|
New FDA bonus pilot to address ‘workforce challenges’news2026-03-05T19:40:48+00:00March 5th, 2026|Endpoints News|
FDA puts PepGen’s Phase 2 muscle disease trial on partial holdnews2026-03-05T12:02:30+00:00March 5th, 2026|Endpoints News|
FDA’s top operating official Butler to retire, deputy to take over in Aprilnews2026-03-04T18:25:30+00:00March 4th, 2026|Endpoints News|
Airiver Medical Granted FDA’s Breakthrough Device Designation for Pulmonary Drug Coated Balloon to Treat Central Airway Stenosis; First Patient Treated in Clinical Trialnews2026-03-04T16:04:11+00:00March 4th, 2026|Medical Device News Magazine|
Expanded FDA 510(k) Clearance Supercharges Bayer’s MEDRAD® MRXperion System for Broader MR Deploymentnews2026-03-04T15:18:50+00:00March 4th, 2026|Medical Device News Magazine|
